Blood test could revolutionize how doctors track sarcoma
NCT ID NCT06958107
Summary
This study is testing a new blood test to find tiny pieces of cancer DNA from sarcoma, a type of bone or soft tissue cancer. It will enroll 300 patients of all ages, including children, who have or are suspected of having sarcoma. The goal is to see if this 'liquid biopsy' can help doctors better diagnose the disease, monitor how well treatment is working, and spot if the cancer comes back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITINGWinston-Salem, North Carolina, 27103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.